文献速递复苏、休克与脓毒症消化、代谢与肾脏急症重症综合管理与镇静镇痛

尼古丁改善内毒素大鼠的生存率、低血压及受损的腺苷能肾血管舒张:α7-nAChRs/HO-1通路的作用

Nicotine Improves Survivability, Hypotension, and Impaired Adenosinergic Renal Vasodilations in Endotoxic Rats: Role of α7-nAChRs/HO-1 Pathway.
PubMed 文献 · Shock · 2020-01-01
一句话结论内毒素大鼠中尼古丁经α7-nAChRs/HO-1通路(胆红素介导)剂量依赖性改善生存率、低血压及腺苷能肾血管舒张,该作用可被α7-nAChR阻断剂或HO-1抑制剂消除。

本研究在大鼠内毒素血症模型中检验功能性α7-nAChRs/HO-1通路是否为尼古丁拮抗血流动力学和肾血管功能障碍所必需。脂多糖(LPS,5 mg/kg 腹腔注射)6小时处理降低收缩压及NECA引起的肾血管舒张(对ACh引起的无影响),升高死亡率及血清尿素、肌酐,除低血压和死亡率升高在雄性更明显外这些效应与性别无关。联合给予尼古丁(0.5、1、2 mg/kg)剂量依赖性逆转上述LPS效应;尼古丁对NECA血管舒张、生存率和肾生物标志物的有利作用在合用甲基牛扁亭柠檬酸盐(α7-nAChR阻断剂)或锌原卟啉(HO-1抑制剂)后消失,并可被胆红素复制,但血红素(HO-1诱导剂)或三羰基二氯钌(II)二聚体(一氧化碳释放分子)不能复制。作者认为α7-nAChRs及HO-1信号通路的胆红素副产物在尼古丁拮抗内毒素大鼠肾功能障碍和腺苷能肾血管舒张能力下降中起关键作用。

要点

  • LPS 5 mg/kg 腹腔注射6小时使大鼠收缩压下降、NECA(1.6–100 nmol)引起的肾血管舒张减弱(ACh 0.01–7.29 nmol引起的无变化),并升高死亡率及血清尿素、肌酐。
  • 尼古丁0.5、1、2 mg/kg剂量依赖性逆转LPS对NECA血管舒张、生存率和肾生物标志物的不利影响。
  • 尼古丁的有益作用在合用甲基牛扁亭柠檬酸盐(α7-nAChR阻断剂)或锌原卟啉(HO-1抑制剂)后消失。
  • 胆红素可复制尼古丁的有益作用,而血红素(HO-1诱导剂)或三羰基二氯钌(II)二聚体(一氧化碳释放分子)不能复制。
  • LPS的效应除低血压和死亡率升高在雄性大鼠更明显外与性别无关。

适用人群与场景

  • 雄性及雌性大鼠,LPS 5 mg/kg腹腔注射6小时诱导的急性内毒素血症模型;离体苯肾上腺素预收缩灌注肾用于肾血管舒张测定。

处置流程与药物剂量

  • 尼古丁0.5、1、2 mg/kg与LPS联合给药,剂量依赖性改善NECA肾血管舒张、生存率及肾生物标志物。
  • 甲基牛扁亭柠檬酸盐(α7-nAChR阻断剂)或锌原卟啉(HO-1抑制剂)与尼古丁同时暴露可消除尼古丁的有益作用。
  • 胆红素处理可复制尼古丁对NECA血管舒张、生存率和肾生物标志物的有益作用;血红素(HO-1诱导剂)或三羰基二氯钌(II)二聚体(一氧化碳释放分子)不能复制。

研究设计与关键结果

  • 动物实验:LPS 5 mg/kg腹腔注射6小时降低收缩压、减弱NECA(1.6–100 nmol)引起的肾血管舒张(ACh 0.01–7.29 nmol引起的无变化),升高死亡率及血清尿素、肌酐。
  • 尼古丁0.5、1、2 mg/kg剂量依赖性逆转LPS的上述效应;低血压和死亡率升高在雄性大鼠更明显,其余LPS效应与性别无关。
  • 尼古丁对NECA血管舒张、生存率和肾生物标志物的有益作用在合用甲基牛扁亭柠檬酸盐或锌原卟啉后消失,可被胆红素复制,但不能被血红素或三羰基二氯钌(II)二聚体复制。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠内毒素血症模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文为动物实验,未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The nicotinic/cholinergic antiinflammatory pathway protects against acute kidney injury and other end-organ damages induced by endotoxemia. In this study, we tested the hypothesis that functional α7-nAChRs/heme oxygenase-1 (HO-1) pathway is imperative for the nicotine counteraction of hemodynamic and renovascular dysfunction caused by acute endotoxemia in rats. Renal vasodilations were induced by cumulative bolus injections of acetylcholine (ACh, 0.01 nmol-7.29 nmol) or ethylcarboxamidoadenosine (NECA, adenosine receptor agonist, 1.6 nmol-100 nmol) in isolated phenylephrine-preconstricted perfused kidneys. The data showed that 6-h treatment with lipopolysaccharide (LPS, 5 mg/kg i.p.) decreased systolic blood pressure and renal vasodilations caused by NECA but not Ach. The endotoxic insult also increased the mortality rate and elevated serum urea and creatinine. These LPS effects were sex-unrelated, except hypotension, and enhanced mortality which were more evident in male rodents, and abrogated after co-administration of nicotine (0.5, 1 mg/kg and 2 mg/kg) in a dose-dependent fashion. The advantageous effects of nicotine on NECA vasodilations, survivability, and kidney biomarkers in endotoxic male rats disappeared upon concurrent exposure to methyllycaconitine citrate (α7-nAChR blocker) or zinc protoporphyrin (HO-1 inhibitor) and were reproduced after treatment with bilirubin, but not hemin (HO-1 inducer) or tricarbonyldichlororuthenium (II) dimer (carbon monoxide-releasing molecule). Together, current biochemical and pharmacological evidence suggests key roles for α7-nAChRs and the bilirubin byproduct of the HO-1 signaling in the nicotine counteraction of renal dysfunction and reduced adenosinergic renal vasodilator capacity in endotoxic rats.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wedn AM, El-Gowilly SM, El-Mas MM, et al. Nicotine Improves Survivability, Hypotension, and Impaired Adenosinergic Renal Vasodilations in Endotoxic Rats: Role of α7-nAChRs/HO-1 Pathway. Shock. 2020. PMID: 31135706. doi:10.1097/SHK.0000000000001384

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。